Unihealth Hospitals Ltd
Incorporated in 2010, Unihealth Consultancy Ltd is in the business of Medical Tour Operator and Health Consultancy Service & Trader in Medical Equipments[1]
- Market Cap ₹ 245 Cr.
- Current Price ₹ 159
- High / Low ₹ 191 / 120
- Stock P/E 105
- Book Value ₹
- Dividend Yield 0.00 %
- ROCE 4.72 %
- ROE 3.55 %
- Face Value ₹ 10.0
Pros
- Company is almost debt free.
Cons
- Company has a low return on equity of 5.90% over last 3 years.
- Earnings include an other income of Rs.3.31 Cr.
- Company has high debtors of 298 days.
- Working capital days have increased from 266 days to 411 days
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| 0.63 | 1.61 | 1.92 | 4.23 | 3.56 | |
| 0.94 | 0.79 | 1.36 | 2.26 | 3.35 | |
| Operating Profit | -0.31 | 0.82 | 0.56 | 1.97 | 0.21 |
| OPM % | -49.21% | 50.93% | 29.17% | 46.57% | 5.90% |
| 0.06 | 0.94 | 1.79 | 2.33 | 3.31 | |
| Interest | 0.80 | 1.19 | 1.15 | 0.36 | 0.03 |
| Depreciation | 0.11 | 0.09 | 0.08 | 0.16 | 0.28 |
| Profit before tax | -1.16 | 0.48 | 1.12 | 3.78 | 3.21 |
| Tax % | 0.00% | 0.00% | -19.64% | 19.84% | 27.41% |
| -1.16 | 0.48 | 1.34 | 3.04 | 2.33 | |
| EPS in Rs | |||||
| Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
| Compounded Sales Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 30% |
| TTM: | -16% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 69% |
| TTM: | -23% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | % |
| 1 Year: | 0% |
| Return on Equity | |
|---|---|
| 10 Years: | % |
| 5 Years: | % |
| 3 Years: | 6% |
| Last Year: | 4% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Equity Capital | 1.34 | 1.34 | 1.39 | 15.40 | 15.40 |
| Reserves | 4.69 | 5.17 | 11.28 | 49.07 | 51.41 |
| 6.96 | 11.60 | 12.08 | 3.30 | 2.66 | |
| 3.67 | 0.42 | 0.61 | 0.71 | 0.95 | |
| Total Liabilities | 16.66 | 18.53 | 25.36 | 68.48 | 70.42 |
| 1.60 | 1.50 | 1.42 | 3.09 | 3.15 | |
| CWIP | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Investments | 6.15 | 6.15 | 6.34 | 18.37 | 30.50 |
| 8.91 | 10.88 | 17.60 | 47.02 | 36.77 | |
| Total Assets | 16.66 | 18.53 | 25.36 | 68.48 | 70.42 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| -0.32 | 2.25 | 1.97 | -2.44 | 0.57 | |
| 0.06 | -6.13 | -7.17 | -10.50 | -21.93 | |
| 0.19 | 3.93 | 5.09 | 39.55 | -1.13 | |
| Net Cash Flow | -0.07 | 0.05 | -0.11 | 26.61 | -22.48 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
| Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | |
|---|---|---|---|---|---|
| Debtor Days | 857.46 | 476.09 | 117.86 | 225.21 | 298.36 |
| Inventory Days | 0.00 | ||||
| Days Payable | |||||
| Cash Conversion Cycle | 857.46 | 476.09 | 117.86 | 225.21 | 298.36 |
| Working Capital Days | 4,745.00 | 562.24 | 26.61 | 361.55 | 411.14 |
| ROCE % | 10.74% | 10.59% | 8.95% | 4.72% |
Documents
Announcements
-
Quarterly Compliance Report on Corporate governance - within 21 days from the end of the quarter
11 October 2025 - States corporate governance provisions not applicable due to SME listing; no compliance report for 30.09.2025.
-
Certificate under SEBI (Depositories and Participants) Regulations, 2018
8 October 2025 - Certificate under Reg 74(5) for quarter ended 30 Sept 2025 confirming dematerialisation actions by Bigshare RTA.
-
Trading Window
30 September 2025 - Trading window closed from Oct 1, 2025 until 48 hours after board meeting approving H1 Sep 30, 2025 results.
-
Shareholders meeting
29 September 2025 - All five AGM resolutions on Sept 29, 2025 passed, including FY2025 accounts, director reappointment, approvals for four related-party transactions.
-
Shareholders meeting
29 September 2025 - All five AGM resolutions passed on September 29, 2025, including material related-party approvals and director reappointment.
Annual reports
Concalls
-
May 2025Transcript PPT
-
Nov 2024Transcript PPT REC
-
May 2024Transcript PPT
-
Nov 2023Transcript PPT
Business Overview:[1]
Headquartered in Mumbai, Unihealth Hospitals Ltd is a diversified healthcare service provider with a global presence, particularly in Africa. The company operates under the 'UMC Hospitals' brand and provides:
- Hospital and medical centre services,
- Healthcare consultancy and project management,
- Export and distribution of pharmaceutical and medical consumables,
- Medical value travel facilitation for international patients.